{"Symbol": "AMLX", "AssetType": "Common Stock", "Name": "Amylyx Pharmaceuticals Inc", "Description": "Amylyx Pharmaceuticals Inc (AMLX) is a biopharmaceutical company at the forefront of developing innovative therapies for neurodegenerative diseases, particularly amyotrophic lateral sclerosis (ALS). Its lead candidate, AMX0035, represents a breakthrough in ALS treatment through its unique combination approach aimed at neuroprotection and enhancing patient quality of life. With a solid pipeline backed by comprehensive clinical programs and a deep understanding of neurological disease mechanisms, Amylyx is strategically positioned to address critical unmet medical needs and drive advancements in the treatment landscape for ALS and related disorders.", "CIK": "1658551", "Exchange": "NASDAQ", "Currency": "USD", "Country": "USA", "Sector": "HEALTHCARE", "Industry": "DRUG MANUFACTURERS - SPECIALTY & GENERIC", "Address": "43 THORNDIKE STREET, CAMBRIDGE, MA, UNITED STATES, 02141", "OfficialSite": "https://amylyx.com", "FiscalYearEnd": "December", "LatestQuarter": "2025-09-30", "MarketCapitalization": "1550652000", "EBITDA": "-192966000", "PERatio": "None", "PEGRatio": "None", "BookValue": "3.025", "DividendPerShare": "None", "DividendYield": "None", "EPS": "-1.79", "RevenuePerShareTTM": "-0.008", "ProfitMargin": "0", "OperatingMarginTTM": "291.04", "ReturnOnAssetsTTM": "-0.394", "ReturnOnEquityTTM": "-0.565", "RevenueTTM": "-665000", "GrossProfitTTM": "-92748000", "DilutedEPSTTM": "-1.79", "QuarterlyEarningsGrowthYOY": "0", "QuarterlyRevenueGrowthYOY": "-0.996", "AnalystTargetPrice": "21.11", "AnalystRatingStrongBuy": "0", "AnalystRatingBuy": "10", "AnalystRatingHold": "1", "AnalystRatingSell": "0", "AnalystRatingStrongSell": "0", "TrailingPE": "-", "ForwardPE": "2.774", "PriceToSalesRatioTTM": "4.438", "PriceToBookRatio": "4.674", "EVToRevenue": "6446.63", "EVToEBITDA": "-11.71", "Beta": "-0.3", "52WeekHigh": "17.49", "52WeekLow": "2.6", "50DayMovingAverage": "13.48", "200DayMovingAverage": "10.55", "SharesOutstanding": "109820000", "SharesFloat": "81565000", "PercentInsiders": "7.526", "PercentInstitutions": "109.199", "DividendDate": "None", "ExDividendDate": "None"}